Assessing the Impact of Colchicine on Pulmonary Fibrosis Using Imaging in Patients With Moderate‐to‐Severe COVID‐19 Pneumonia
This study demonstrates that colchicine therapy might reduce pulmonary fibrosis progression in individuals affected by COVID-19 pneumonia. Clinicians should consider colchicine treatment to prevent pulmonary fibrosis.
Authors
- Gülhan AYHAN ALBAYRAK (ORCID: https://orcid.org/0000-0003-1802-3844)
- Ugur Temel
- Mustafa Ilteris Bardakci
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Şişli Etfal Eğitim ve Araştırma Hastanesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Canadian Respiratory Journal
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1155/carj/9923052
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00